1. Home
  2. OCSL vs PCRX Comparison

OCSL vs PCRX Comparison

Compare OCSL & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oaktree Specialty Lending Corporation

OCSL

Oaktree Specialty Lending Corporation

HOLD

Current Price

$11.75

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$23.50

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OCSL
PCRX
Founded
2007
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
2007
2010

Fundamental Metrics

Financial Performance
Metric
OCSL
PCRX
Price
$11.75
$23.50
Analyst Decision
Hold
Strong Buy
Analyst Count
4
4
Target Price
$12.63
$30.25
AVG Volume (30 Days)
750.9K
516.5K
Earning Date
05-05-2026
04-30-2026
Dividend Yield
12.73%
N/A
EPS Growth
N/A
107.44
EPS
N/A
0.07
Revenue
N/A
$541,533,000.00
Revenue This Year
N/A
$6.78
Revenue Next Year
$0.31
$8.54
P/E Ratio
N/A
$336.29
Revenue Growth
N/A
26.04
52 Week Low
$10.63
$18.80
52 Week High
$14.77
$27.64

Technical Indicators

Market Signals
Indicator
OCSL
PCRX
Relative Strength Index (RSI) 39.96 49.85
Support Level $10.88 $22.13
Resistance Level $13.19 $24.20
Average True Range (ATR) 0.28 1.02
MACD -0.08 -0.06
Stochastic Oscillator 11.89 42.93

Price Performance

Historical Comparison
OCSL
PCRX

About OCSL Oaktree Specialty Lending Corporation

Oaktree Specialty Lending Corp is a specialty finance company. The company provides lending services and invests in small and mid-sized companies. The company's investment objective is to maximize its portfolio's total return by generating current income from debt investments, and to a lesser extent, capital appreciation from equity investments. The company provides customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets. The company operates as a single reportable segment and derives revenues from investing in originated loans and other securities, including broadly syndicated loans, of U.S. private companies and manages the business on a consolidated basis.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: